A Multi-cohort Phase II Study of HER2-positive and Triple-negative Breast Cancer Brain Metastases.
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Pyrotinib|DRUG: Temozolomide Injection|DRUG: SHR-1316|DRUG: Bevacizumab|DRUG: Cisplatin/Carboplatin
Sponsor: Fudan University